Interview: Victor Casasola – CEO, Canitec, Mexico

1 (5)Victor Casasola, CEO at Canitec, explains the unique business model of his Mexican medical devices success story, offering an integral service to its clients, and showcases the high added value and quality of its broad portfolio of laboratory equipment. Could you please introduce to our international audience the key activities and operations of Canitec?
"The genomics and pharmaceutical business lines are our main contributors, representing around 75 percent of our total revenues."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report